Conserved residues at the MAPKs binding interfaces that regulate transcriptional machinery

References

• Ben-Levy, R., Leighton, I. A., Doza, Y. N., Attwood, P., Morrice, N., Marshall, C. J., & Cohen, P. (1995). Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2. EMBO Journal, 14, 5920–5930.
   PubMed Web of Science ®Google Scholar
• Bennett-Lovsey, R. M., Herbert, A. D., Sternberg, M. J., & Kelley, L. A. (2008). Exploring the extremes of sequence/structure space with ensemble fold recognition in the program Phyre. Proteins, 70, 611–625.
   PubMed Web of Science ®Google Scholar
• Biondi, R. M., & Nebreda, A. R. (2003). Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions. Biochemical Journal, 372, 1–13.10.1042/BJ20021641
   PubMed Web of Science ®Google Scholar
• Brooks, B. R., Brooks, C. L., 3rd, Mackerell, A. D., Jr., Nilsson, L., Petrella, R. J., Roux, B., … Karplus, M. (2009). CHARMM: The biomolecular simulation program. Journal of Computational Chemistry, 30, 1545–1614.10.1002/jcc.v30:10
   PubMed Web of Science ®Google Scholar
• Channavajhala, P. L., Wu, L., Cuozzo, J. W., Hall, J. P., Liu, W., Lin, L. L., & Zhang, Y. (2003). Identification of a novel human kinase supporter of Ras (hKSR-2) that functions as a negative regulator of Cot (Tpl2) signaling. Journal of Biological Chemistry, 278, 47089–47097.10.1074/jbc.M306002200
   PubMed Web of Science ®Google Scholar
• Chen, H., Lyne, P. D., Giordanetto, F., Lovell, T., & Li, J. (2006). On evaluating molecular-docking methods for pose prediction and enrichment factors. Journal of Chemical Information and Modeling, 46, 401–415.10.1021/ci0503255
   PubMed Web of Science ®Google Scholar
• Cole, C., Barber, J. D., & Barton, G. J. (2008). The Jpred 3 secondary structure prediction server. Nucleic Acids Research, 36, W197–W201.10.1093/nar/gkn238
   PubMed Web of Science ®Google Scholar
• Dalby, K. N., Morrice, N., Caudwell, F. B., Avruch, J., & Cohen, P. (1998). Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK. Journal of Biological Chemistry, 273, 1496–1505.10.1074/jbc.273.3.1496
   PubMed Web of Science ®Google Scholar
• Ellinger-Ziegelbauer, H., Kelly, K., & Siebenlist, U. (1999). Cell cycle arrest and reversion of Ras-induced transformation by a conditionally activated form of mitogen-activated protein kinase kinase kinase 3. Molecular Cell Biology, 19, 3857–3868.
   PubMed Web of Science ®Google Scholar
• Frödin, M., & Gammeltoft, S. (1999). Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Molecular and Cellular Endocrinology, 151, 65–77.10.1016/S0303-7207(99)00061-1
   PubMed Web of Science ®Google Scholar
• Fukuda, M., Gotoh, Y., & Nishida, E. (1997). Interaction of MAP kinase with MAP kinase kinase: Its possible role in the control of nucleocytoplasmic transport of MAP kinase. The EMBO Journal, 16, 1901–1908.10.1093/emboj/16.8.1901
   PubMed Web of Science ®Google Scholar
• Gavin, A. C., & Nebreda, A. R. (1999). A MAP kinase docking site is required for phosphorylation and activation of p90rsk/MAPKAP kinase-1. Current Biology, 9, 281–286.10.1016/S0960-9822(99)80120-1
   PubMed Web of Science ®Google Scholar
• Gong, X. W., Wei, J., Li, Y. S., Cheng, W. W., Deng, P., & Jiang, Y. (2008). Effect of p38 mitogen-activated protein kinase gene knockout on cell proliferation of embryonic fibroblasts in mice. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 20, 527–529.
   PubMedGoogle Scholar
• Hanks, S. K., Quinn, A. M., & Hunter, T. (1988). The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains. Science, 241, 42–52.10.1126/science.3291115
   PubMed Web of Science ®Google Scholar
• He, Y. Y., Cai, B., Yang, Y. X., Liu, X. L., & Wan, X. P. (2009). Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway. Cancer Science, 100, 1051–1061.10.1111/cas.2009.100.issue-6
   PubMed Web of Science ®Google Scholar
• Hilger, R. A., Scheulen, M. E., & Strumberg, D. (2002). The Ras-Raf-MEK-ERK pathway in the treatment of cancer. Onkologie, 25, 511–518.10.1159/000068621
   PubMed Web of Science ®Google Scholar
• Igata, M., Motoshima, H., Tsuruzoe, K., Kojima, K., Matsumura, T., Kondo, T., … Araki, E. (2005). Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression. Circulation Research, 97, 837–844.10.1161/01.RES.0000185823.73556.06
   PubMed Web of Science ®Google Scholar
• Jones, S. W., Erikson, E., Blenis, J., Maller, J. L., & Erikson, R. L. (1988). A Xenopus ribosomal protein S6 kinase has two apparent kinase domains that are each similar to distinct protein kinases. Proceedings of the National Academy of Sciences USA, 85, 3377–3381.10.1073/pnas.85.10.3377
   PubMed Web of Science ®Google Scholar
• Kyte, J., & Doolittle, R. F. (1982). A simple method for displaying the hydropathic character of a protein. Journal of Molecular Biology, 157, 105–132.10.1016/0022-2836(82)90515-0
   PubMed Web of Science ®Google Scholar
• Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H., … Higgins, D. G. (2007). Clustal W and Clustal X version 2.0. Bioinformatics, 23, 2947–2948.10.1093/bioinformatics/btm404
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., Rullmannn, J. A., MacArthur, M. W., Kaptein, R., & Thornton, J. M. (1996). AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. Journal of Biomolecular NMR, 8, 477–486.
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., & Swindells, M. B. (2011). LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery. Journal of Chemical Information and Modeling, 51, 2778–2786.10.1021/ci200227u
   PubMed Web of Science ®Google Scholar
• Lüthy, R., Bowie, J. U., & Eisenberg, D. (1992). Assessment of protein models with three-dimensional profiles. Nature, 356, 83–85.10.1038/356083a0
   PubMed Web of Science ®Google Scholar
• Mabuchi, S., Ohmichi, M., Kimura, A., Ikebuchi, Y., Hisamoto, K., Arimoto-Ishida, E., … Murata, Y. (2004). Tamoxifen inhibits cell proliferation via mitogen-activated protein kinase cascades in human ovarian cancer cell lines in a manner not dependent on the expression of estrogen receptor or the sensitivity to cisplatin. Endocrinology, 145, 1302–1313.10.1210/en.2003-0709
   PubMed Web of Science ®Google Scholar
• Müller, A., MacCallum, R. M., & Sternberg, M. J. (1999). Benchmarking PSI-BLAST in genome annotation. Journal of Molecular Biology, 293, 1257–1271.10.1006/jmbi.1999.3233
   PubMed Web of Science ®Google Scholar
• Nguyen, T. L. (2008). Targeting RSK: An overview of small molecule inhibitors. Anti-Cancer Agents in Medicinal Chemistry, 8, 710–716.10.2174/187152008785914770
   PubMed Web of Science ®Google Scholar
• Petsalaki, E., Stark, A., García-Urdiales, E., & Russell, R. B. (2009). Accurate prediction of peptide binding sites on protein surfaces. PLoS Computational Biology, 5, e1000335.10.1371/journal.pcbi.1000335
   PubMed Web of Science ®Google Scholar
• Poteet-Smith, C. E., Smith, J. A., Lannigan, D. A., Freed, T. A., & Sturgill, T. W. (1999). Generation of constitutively active p90 ribosomal S6 kinase in vivo. Implications for the mitogen-activated protein kinase-activated protein kinase family. Journal of Biological Chemistry, 274, 22135–22138.10.1074/jbc.274.32.22135
   PubMed Web of Science ®Google Scholar
• Roux, P. P., & Blenis, J. (2004). ERK and p38 MAPK-activated protein kinases: A family of protein kinases with diverse biological functions. Microbiology and Molecular Biology Reviews, 68, 320–344.10.1128/MMBR.68.2.320-344.2004
   PubMed Web of Science ®Google Scholar
• Roux, P. P., Richards, S. A., & Blenis, J. (2003). Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity. Journal of Molecular Cell Biology, 23, 4796–4804.
   Web of Science ®Google Scholar
• Roux, P. P., Shahbazian, D., Vu, H., Holz, M. K., Cohen, M. S., Taunton, J., … Blenis, J. (2007). RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation. Journal of Biological Chemistry, 282, 14056–14064.10.1074/jbc.M700906200
   PubMed Web of Science ®Google Scholar
• Rubinfeld, H., Hanoch, T., & Seger, R. (1999). Identification of a cytoplasmic-retention sequence in ERK2. Journal of Biological Chemistry, 274, 30349–30352.10.1074/jbc.274.43.30349
   PubMed Web of Science ®Google Scholar
• Satomi, Y., & Nishino, H. (2009). Implication of mitogen-activated protein kinase in the induction of G1 cell cycle arrest and gadd45 expression by the carotenoid fucoxanthin in human cancer cells. Biochimica et Biophysica Acta, 1790, 260–266.10.1016/j.bbagen.2009.01.003
   PubMed Web of Science ®Google Scholar
• Shi, F., Chiu, Y. J., Cho, Y., Bullard, T. A., Sokabe, M., & Fujiwara, K. (2007). Down-regulation of ERK but not MEK phosphorylation in cultured endothelial cells by repeated changes in cyclic stretch. Cardiovascular Research, 73, 813–822.10.1016/j.cardiores.2006.12.014
   PubMed Web of Science ®Google Scholar
• Skarpen, E., Flinder, L. I., Rosseland, C. M., Orstavik, S., Wierod, L., Oksvold, M. P., … Huitfeldt, H. S. (2008). MEK1 and MEK2 regulate distinct functions by sorting ERK2 to different intracellular compartments. FASEB Journal, 22, 466–476.
   PubMed Web of Science ®Google Scholar
• Smith, J. A., Poteet-Smith, C. E., Malarkey, K., & Sturgill, T. W. (1999). Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo. Journal of Biological Chemistry, 274, 2893–2898.10.1074/jbc.274.5.2893
   PubMed Web of Science ®Google Scholar
• Tarrega, C., Rios, P., Cejudo-Marin, R., Blanco-Aparicio, C., van den Berk, L., Schepens, J., … Pulido, R. (2005). ERK2 shows a restrictive and locally selective mechanism of recognition by its tyrosine phosphatase inactivators not shared by its activator MEK1. Journal of Biological Chemistry, 280, 37885–37894.10.1074/jbc.M504366200
   PubMed Web of Science ®Google Scholar
• Terai, K., & Matsuda, M. (2005). Ras binding opens c-Raf to expose the docking site for mitogen-activated protein kinase kinase. EMBO Reports, 6, 251–255.10.1038/sj.embor.7400349
   PubMed Web of Science ®Google Scholar
• Tian, T., & Song, J. (2012). Mathematical modelling of the MAP kinase pathway using proteomic datasets. PLoS One, 7, e42230.10.1371/journal.pone.0042230
   PubMed Web of Science ®Google Scholar
• Xu, B., Stippec, S., Robinson, F. L., & Cobb, M. H. (2001). Hydrophobic as well as charged residues in both MEK1 and ERK2 are important for their proper docking. Journal of Biological Chemistry, 276, 26509–26515.10.1074/jbc.M102769200
   PubMed Web of Science ®Google Scholar
• Zhang, Y. (2008). I-TASSER server for protein 3D structure prediction. BMC Bioinformatics, 9, 40.10.1186/1471-2105-9-40
   PubMed Web of Science ®Google Scholar
• Zhang, Y. X., & Kong, C. Z. (2008). The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: An in vitro experiment. Zhonghua Yi Xue Za Zhi, 88, 271–275.
   PubMedGoogle Scholar